With over two decades of experience in the biotechnology and pharmaceutical sectors, Marc currently serves as Senior Director of Global Commercial Operations for HIV at Gilead Sciences. In this role, he oversees global commercial strategies and operations, contributing to the advancement of HIV treatments worldwide.

Marc is actively involved in shaping the future of pharmaceutical commercialization. He has participated in panels discussing global commercialization strategies and the integration of artificial intelligence in the pharmaceutical industry.

Beyond his corporate responsibilities, Marc is a member of the Digital Pharma Circle, a network of decision-makers in the pharma digital health space, fostering discussions that generate meaningful insights on digital transformation in the sector.